Loading…

WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens: I. Taxonomy, Production, Purification and Biological Properties

WF14865A and B, novel cathepsins B and L inhibitors, were produced and isolated separately from the culture mycelium of a fungal strain Aphanoascus fulvescens No. 14865. Spectroscopic analysis revealed that both WF 14865A and B were composed of trans-epoxysuccinyl moieties, 1-H-imidazole-2-ylamine,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antibiotics 2000/05/25, Vol.53(5), pp.449-458
Main Authors: OTSUKA, TAKANAO, MURAMATSU, YUKO, NAKANISHI, TOMOKO, HATANAKA, HIROSHI, OKAMOTO, MASANORI, HINO, MOTOHIRO, HASHIMOTO, SEIJI
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:WF14865A and B, novel cathepsins B and L inhibitors, were produced and isolated separately from the culture mycelium of a fungal strain Aphanoascus fulvescens No. 14865. Spectroscopic analysis revealed that both WF 14865A and B were composed of trans-epoxysuccinyl moieties, 1-H-imidazole-2-ylamine, and isoleucine or leucine. These compounds inhibited human cathepsins B and L with IC50 values in the range of 8.4-72 nM in vitro. Though their in vitro properties were typical as trans-epoxysuccmyl type inhibitors, they exerted strong bone resorption inhibitory effects in low-calcium-diet-fed mouse model at 3.2-10mg/kg.
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.53.449